Skip to main content
. 2024 Mar 30;23:114. doi: 10.1186/s12933-024-02197-z

Fig. 2.

Fig. 2

Cumulative incidences of adverse events in groups divided by median levels of total, active and inactive plasma SDF-1α. a Cumulative incidences of all-cause death and 3P-MACE in patients with high and low plasma total SDF-1α levels. b Cumulative incidences of all-cause death and 3P-MACE in patients with high and low plasma active SDF-1α levels. c Cumulative incidences of all-cause death and 3P-MACE in patients with high and low plasma inactive SDF-1α levels